Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

68 results about "Stem cell line" patented technology

A stem cell line is a group of stem cells that is cultured in vitro and can be propagated indefinitely. Stem cell lines are derived from either animal or human tissues and come from one of three sources: embryonic stem cells, adult stem cells, or induced stem cells. They are commonly used in research and regenerative medicine.

Engineered mucosal-associated invariant t (MAIT) cells and methods of making and using thereof

Embodiments of the invention include compositions and methods related to engineered human mucosal-associated invariant T (eMAIT) cells for off-the-shelf use for clinical therapy for cancer, infectious, and autoimmune diseases. In some embodiments, the eMAIT cells are produced from healthy human donor peripheral blood, cord blood, or G-CSF mobilized peripheral blood. In particular embodiments, the eMAIT cells are produced from a pluripotent stem cell line and therefore can be of unlimited supply. In some embodiments, the eMAIT cells are engineered to express chimeric antigen receptors (CARs), or / and immune regulatory molecules, or / and allorejection resistance molecules. Embodiments of the invention also include compositions of matter comprising polynucleotides encoding mucosal-associated invariant T cell receptor alpha chain polypeptides and / or mucosal-associated invariant T cell receptor beta chain polypeptides.
Owner:RGT UNIV OF CALIFORNIA

Preparation method and therapeutic application of stem cell exosome loaded with therapeutic molecules

The invention belongs to the technical field of stem cell exosome preparation, and provides a preparation method and therapeutic application of a stem cell exosome loaded with therapeutic molecules, and the preparation method comprises the following steps: S1, selecting and culturing a stem cell line with exosome secretion capability; s2, in the stem cell culture process, adding selected therapeutic molecules, so that the therapeutic molecules can be taken by the stem cells and integrated into exosomes of the stem cells; s3, collecting stem cell culture supernate, and separating and purifying the exosome through a differential centrifugation, ultrafiltration or density gradient centrifugation method; s4, identifying the exosome obtained by separation; a stem cell line with efficient exosome secretion capacity is selected and cultured, and selected therapeutic molecules are added in the culture process, so that efficient loading of the therapeutic molecules is realized; according to the method, the operation steps are simplified, the loading efficiency is improved, it is ensured that therapeutic molecules can be stably integrated into the stem cell exosome, and meanwhile the biological activity and stability of the exosome are kept.
Owner:DONGGUAN ENLIAN STEM CELL BIOTECHNOLOGY RES INST

Human-derived recessive retinal degeneration disease organ-like model based on Prom1 gene knockout

The invention provides a human-derived recessive retinal degeneration disease organ-like model based on Prom1 gene knockout. Specifically, the invention provides a specific gRNA targeting a Prom1 gene exon 9, and the specific gRNA can be used for efficiently knocking out the Prom1 gene of the human embryonic stem cell. The invention also provides a Prom1 gene knockout stem cell line derived from the human embryo pluripotent stem cell H9 and a retinal organ disease model. The retina-like organ can provide a research model for clinical treatment drugs.
Owner:SHANGHAI LANGSHENG BIOTECHNOLOGY CO LTD

Method of producing immortalized clonal mesenchymal stem cells (HMSCS) from HLA homozygous human induced pluripotent stem cells (hipsc’s) derived from cord blood

The invention relates to a method of producing a clonal mesenchymal stem cell line capable of producing exosomes (MSC-derived extracellular vesicles) comprising the steps of, providing human induced pluripotent stem cells (hiPSCs), generating therefrom an immortalized clonal cell line of mesenchymal stem cells (IMSC), optionally characterizing the potential of the IMSCs to produce exosomes. The invention also relates to a stem cell line produced according to the invention. The invention relates to the cell line according to the invention, for use as a medicament. The invention relates to the cell line according to the invention for use in treating a disease that is amenable to treatment with stem cell therapy. The invention also relates to the use of a stem cell line according to the invention for producing EVs.
Owner:JENSEN ARNE +1

Method for establishing blunt-snout bream caudal fin-induced pluripotent stem cell line and application thereof

The present invention discloses a method for establishing and applying a caudal fin-induced pluripotent stem cell line of Erythroculter ilishaeformis. By the tissue adherence method, a cell line with high proliferation performance and stemness is isolated from the caudal fin of Erythroculter ilishaeformis. In the early stage, the cells of this cell line are significantly fibroblast-like. Later, the cells become smaller but still maintain a spindle shape, without obvious contact inhibition phenomenon, and can spontaneously form cell clusters similar to induced pluripotent stem cells. Alkaline phosphatase staining is positive and it expresses stemness marker genes such as Oct4, Sox2, Klf4, Nanog, and c-Myc. The present invention uses a single cAMP agonist small molecule compound to reverse the phenomenon of weakened stemness after continuous subculture of this cell line, enabling it to maintain the characteristics of high proliferation performance and high stemness, which is suitable for future research on the induction and differentiation of fish stem cells and provides more choices for the research and application of fish stem cells.
Owner:ZHEJIANG UNIV

Recombinant lentivirus capable of indicating bovine spermatogonial stem cell differentiation, spermatogonial stem cell line and application

The invention provides a recombinant lentivirus capable of indicating bovine spermatogonial stem cell differentiation, a spermatogonial stem cell line and application, and belongs to the technical field of cell biology. The invention provides a method for constructing a spermatogonial stem cell line for indicating bovine sperm differentiation on the basis of a lentivirus transduction technology, and a visual detection system for differentiating spermatogonial stem cells into spermatoblasts is constructed by regulating expression of mCherry protein by utilizing a PRM1 promoter. According to the method, the expression of PRM1 is indicated by fluorescent protein mCherry, so that the differentiation process of the bovine spermatogonial stem cells is indicated, and a good tool is provided for the induction of differentiation of the bovine spermatogonial stem cells to sperms, the research of a development mechanism and the optimization of a differentiation system of the bovine spermatogonial stem cells. The method is a new way for solving the neck clamping problem that good-variety bovine sperms are difficult to obtain in scientific research and production, can also be used for optimization of a spermatogonial stem cell differentiation system, sorting and purification of sperms, even downstream research of drug screening and the like, and has a good application prospect.
Owner:NORTHWEST A & F UNIV

A method for isolating and culturing a formation layer stem cell of burdock

This invention discloses a method for inducing and culturing burdock stem cells and stem cells, belonging to the field of plant biotechnology. Using burdock roots as explants, the cambium is determined by staining, and the cambium is obtained using enzymatic digestion. The cambium is then inoculated into a specific ratio of induction solid medium and cultured in the dark to efficiently induce primary stem cells. These primary stem cells are then transferred to a proliferation solid medium for subculture and selection to obtain and maintain a vigorous, soft stem cell line. The solid stem cell line is further transferred to a liquid medium for shaking culture to establish a suspension stem cell line. This invention provides high induction efficiency, stable stem cell characteristics, and good reproducibility, offering a high-quality starting material and technical platform for in vitro preservation of burdock germplasm, large-scale production of secondary metabolites, and genetic transformation.
Owner:XUZHOU NORMAL UNIVERSITY +1

Human trophoblastic stem cell line derived from complete hydatidiform mole and its application

ActiveCN121592585BBiotechnologyStem cell line
This invention belongs to the medical field and provides a human trophoblastic stem cell line derived from complete hydatidiform mole and its applications. The human trophoblastic stem cell line, with accession number CGMCC No. C2024411, can be induced to differentiate into syncytiotrophoblast and extravillous trophoblast, mimicking the differentiation and developmental defects of the trophoblastic lineage in hydatidiform mole. It can be used as an in vitro research model for complete hydatidiform mole and has broad application prospects in drug target research and genetic studies.
Owner:SHANDONG UNIV

Preparation method of purified and immortalized pilose antler stem cell line

The invention discloses a preparation method of a purified and immortalized pilose antler stem cell line, and belongs to the technical field of biology. Comprising the following steps: S1, performing primary culture on pilose antler stem cells to obtain primary cells; s2, purifying the primary cells to obtain a purified cell strain with high multiplication capacity; and S3, carrying out natural immortalization domestication on the purified cell strain to obtain the single natural immortalization antler stem cell line. According to the method, the antler stem cells are subjected to primary culture, purification and immortalized domestication, so that the pure antler stem cell line subjected to infinite passage in a natural state can be obtained, continuous passage can be performed for more than 50 generations, the cost is effectively saved, the immortalized domestication method is realized through repeated passage, the passage is a one-passage two-passage mode, and the immortalized domestication method is simple and convenient. The repeated passage time is once every two days; meanwhile, the antler stem cell line is cloned from one cell, so that the antler stem cell line has relatively high genetic stability.
Owner:长春科技学院 +1

Human homogeneous amniotic fluid stem cell lines and uses thereof

ActiveUS12246040B2DiseaseStem cell line
Homogeneous human amniotic fluid stem cell clones are provided. The clones serve as direct bioassays to test the effect of drugs, nutraceuticals, vitamins and toxic agents on fetus growth, differentiation and development, and may be administered in form of pharmaceutical compositions for reconstructive engineering and for the treatment of cardiac, neurological and osteoarthritic diseases.
Owner:YOUNG BRUCE K +1

Line establishment method and culture system of bovine trophoblast stem cells

The invention discloses a line establishment method and a culture system of bovine trophoblast stem cells. The stem cell line is obtained by separation and induction from bovine blastocyst. The embryonic stem cell line has stability. The method can be applied to various life science and medical fields such as bovine animal breeding and breeding, gene editing models, animal cloned donor cells, medical musculoskeletal injury experiments, drug development carriers, vaccine production cell banks, embryo quality analysis and the like, and can be applied to large-scale production and application.
Owner:INNER MONGOLIA SAIKEXING LIVESTOCK BREEDING & SEED IND BIOTECH RES INST CO LTD +3

A method for stably producing exosomes of sheep umbilical cord mesenchymal stem cells regenerative repair and anti-inflammatory molecules and application in skin care products

PendingCN122146615ACosmetic preparationsAntipyreticLentivirusWharton's jelly
The application discloses a method for stably producing exosomes of regenerative repair and anti-inflammatory molecules of sheep umbilical cord mesenchymal stem cells and application thereof in skin care products, and comprises the following steps: S1, using healthy sheep umbilical cord as raw material, obtaining primary sheep umbilical cord mesenchymal stem cells through aseptic treatment, Wharton's jelly extraction and tissue block adherent culture; S2, introducing an immortalization gene into the primary sheep umbilical cord mesenchymal stem cells through a lentivirus transduction technology, and obtaining an immortalized sheep umbilical cord mesenchymal stem cell line through resistance screening; S3, collecting supernatant after amplification culture of the immortalized sheep umbilical cord mesenchymal stem cell line, and purifying through multi-stage centrifugal impurity removal and PEG precipitation method to obtain stably produced exosomes containing regenerative repair and anti-inflammatory molecules. The exosomes containing regenerative repair and anti-inflammatory molecules provided by the application exhibit significant advantages in yield and quality, and have outstanding application value in the fields of medical beauty anti-aging and skin care products.
Owner:TONGLU HUAYI CELL ENGINEERING CO LTD

Sheep parthenogenetic haploid stem cell culture solution and application thereof

ActiveCN118995582AEmbryonic cellsGerm cellsMaturation oocyteStem cell line
The invention relates to the technical field of biology, in particular to a sheep parthenogenetic haploid stem cell culture solution and application thereof. The method comprises the following steps: performing parthenogenetic activation on a mature oocyte of the sheep to obtain a sheep parthenogenetic embryo, culturing the sheep parthenogenetic embryo in vitro to obtain a blastocyst, and culturing the sheep parthenogenetic blastocyst in a culture solution to obtain the sheep parthenogenetic haploid stem cell. The culture solution comprises an mTeSR1 basic culture solution, FGF2, Activin A, CHIR99021 and XAV939, and every 500 mL of the mTeSR1 basic culture solution contains 5 to 10 ng / mL of the FGF2, 0.5 to 1 [mu] M of the Activin A, 1 to 2.5 [mu] M of the CHIR99021 and 0.5 to 1 [mu] M of the XAV939. The invention provides a culture solution suitable for culturing sheep parthenogenetic haploid stem cells, the sheep parthenogenetic haploid stem cells are obtained, and a sheep parthenogenetic haploid stem cell line is established. The whole genome of the sheep parthenogenetic haploid stem cells is derived from oocytes and has the self-replication ability and pluripotency of the stem cells, and the obtained cell line is a haploid cell line and can be used for gene screening on the cellular level.
Owner:INNER MONGOLIA UNIVERSITY

Immortalized mesenchymal stem cell line capable of simultaneously expressing IL1-RN and COL17AD protein active segments as well as preparation method and application of immortalized mesenchymal stem cell line

The invention provides an immortalized mesenchymal stem cell line capable of simultaneously expressing IL1-RN and COL17AD protein active segments as well as a preparation method and application of the immortalized mesenchymal stem cell line, and belongs to the technical field of genetic engineering. The method specifically comprises the following steps: (1) constructing a pMSCV-BMI-P2A-TERT virus; (2) infecting the mesenchymal stem cells, and performing passage to obtain immortalized mesenchymal stem cells; (3) constructing a pMSCV-IL1-RN-P2A-COL17AD virus (pMSCV-IL1-RN-P2A-COL17AD And (4) infecting the immortalized mesenchymal stem cells by using the pMSCV-IL1-RN-P2A-COL17AD virus obtained in the step (3), and carrying out passage, so as to obtain the immortalized mesenchymal stem cell line capable of simultaneously expressing IL1-RN and COL17AD protein active segments. The cell supernatant of the cell line provided by the invention has the function of promoting skin injury repair, and can be applied to functional cosmetics and skin repair drugs.
Owner:ANKELAI (CHONGQING) BIOMEDICAL TECH CO LTD

Novel non-integrated bovine induced pluripotent stem cell line construction method

The invention relates to the technical field of biology, and discloses a novel non-integrated bovine induced pluripotent stem cell line construction method, which comprises the following steps: selecting a proper cell source, constructing an episomal vector system, introducing an episomal vector into bovine primary fibroblasts by using an electrotransfection method, and screening and culturing the transfected bovine primary fibroblasts in a culture medium to obtain the novel non-integrated bovine induced pluripotent stem cell line. According to the method, positive cells successfully transferred into dry factors are obtained, the cell morphology is monitored in the reprogramming process, along with the progress of reprogramming, more and more pluripotent clones appear in a cell population, amplification and identification are performed through clone culture, and the pluripotency and differentiation potential of the successfully established bovine induced pluripotent stem cells are verified. A stable bovine induced pluripotent stem cell line is established, long-term culture is carried out, and pluripotency and stability of the bovine induced pluripotent stem cell line are verified. Through an episomal non-integration method, the cattle non-integration induced pluripotent stem cell line which can be passaged for multiple times in vitro, is relatively good in hereditary stability and can maintain pluripotency and in-vitro differentiation capacity is constructed.
Owner:CHINA AGRI UNIV

Neural crest stem cell tracing system based on P75NTR-T2A-eGFP and application

The invention belongs to the technical field of gene engineering, and particularly relates to a neural crest stem cell tracing system based on P75NTR-T2A-eGFP and application. The invention focuses on construction and application of a tracing system for differentiating pluripotent stem cells into neural crest stem cells in vitro. By constructing a Crispr / Cas9 vector, a termination codon region of a P75NTR gene expression cassette is precisely targeted. Meanwhile, a gene knock-in vector containing an (LHA) left homologous arm, T2A-eGFP-right homologous arm (RHA) is constructed. The two vectors are introduced into pluripotent stem cells (hPSCs) by means of electric shock transfection. Through the operation, the P75NTR-T2A-eGFP gene knock-in pluripotent stem cell line is successfully obtained, a foundation is laid for building a follow-up tracing system, and the P75NTR-T2A-eGFP gene knock-in pluripotent stem cell line has important application value in the field of neural crest stem cells.
Owner:EIGHTH AFFILIATED HOSPITAL SUN YAT SEN UNIV (SHENZHEN FUTIAN)

Complete grape embryo-derived human trophoblast stem cell line and application thereof

The invention belongs to the field of medicine, and provides a complete grape embryo-derived human trophoblast stem cell line and application thereof. The preservation number of the human trophoblast stem cell line is CGMCC No.C2024411, and the human trophoblast stem cell line can be induced and differentiated into a syncytial trophoblast and an extravillus trophoblast, can simulate differentiation and development defects of a grape embryo trophoblast pedigree, can be applied as an in-vitro research model of a complete grape embryo, and has a wide application prospect in drug target research and genetic research.
Owner:SHANDONG UNIV

Construction method of immortalized goat umbilical cord mesenchymal stem cell line

The invention belongs to the technical field of cell culture, and particularly relates to a construction method of an immortalized goat umbilical cord mesenchymal stem cell line. The method comprises the following steps: by taking newborn goat lamb umbilical cord tissues as a research object, cleaning goat lamb umbilical cords, stripping blood vessels, separating Wharton's jelly, cutting the Wharton's jelly into 1mm < 3 > tissues, culturing by using a DMEM / F12 complete culture medium containing fetal calf serum, carrying out passage, cryopreservation, repeated resuspension and centrifugation, and inoculating into a culture dish for culture; lentiviruses containing SV40 large T antigens are packaged in vitro and are transduced into goat umbilical cord mesenchymal stem cells, and immortalization is realized after long-term subculture. The result of the embodiment shows that the construction method of the immortalized goat umbilical cord mesenchymal stem cell line provided by the invention is strong in repeatability, simple and efficient in operation steps, good in stem cell growth state and stable in physiological state.
Owner:YULIN UNIV +1

An immortalized hair follicle stem cell line and preparation method thereof

The present invention relates to an immortalized hair follicle stem cell line and a preparation method thereof, comprising the following steps: isolating and culturing primary mouse hair follicle stem cells; producing retrovirus supernatant; establishing an immortalized hair follicle stem cell line: inoculating primary hair follicle stem cells; adding polybrene to the virus supernatant collected in step (2); after the cells adhere to the wall, absorbing the culture medium, adding the virus supernatant containing polybrene; replacing the new virus supernatant containing polybrene at a certain interval; adding hygromycin for screening during the second round of liquid replacement; after screening for 3-5 rounds, terminating the screening, and conventionally culturing; the screened cells are immortalized hair follicle stem cells. The immortalized mouse hair follicle stem cells obtained by the present invention can still reconstruct a complete hair follicle structure on nude mice after 40 passages. The problem that hair follicle stem cells cannot be cultured for a long time and lose their dryness after culture is solved, and the labor cost and economic cost of hair follicle stem cell research and application can be greatly reduced.
Owner:ARMY MEDICAL UNIV

Trachinotus ovatus spermatogonial stem cell line and establishment, cryopreservation and recovery method and application thereof

The invention provides a trachinotus ovatus spermatogonial stem cell line as well as establishment, cryopreservation and recovery methods and application thereof, and relates to the technical field of biologication.The method comprises the steps that tissue cells of trachinotus ovatus testis are placed in a complete culture medium to be cultured, and a fresh culture medium is replaced once every 2-4 days within 15 days before culture; culturing until the bottom of the bottle is full of cells, adding a trypsin solution to digest the cells, sucking out the digested cells every 30 seconds, respectively adding a complete culture medium for culturing for three times, screening out high-proportion spermatogonial stem cells for subsequent continuous culture, subculturing to a new culture bottle according to the proportion of 1: (1-3), and culturing to obtain the trachinotus ovatus spermatogonial stem cell line. The trachinotus ovatus spermatogonial stem cells with relatively high purity are obtained by a differential digestion method, and the trachinotus ovatus spermatogonial stem cell line is obtained by setting a passage proportion for culture and can be stably passed. And gene transfection research is carried out, so that technical support is provided for extensive research on spermatogonial stem cells of trachinotus ovatus.
Owner:BEIDAIHE CENT EXPERIMENTAL STATION OF CHINESE ACAD OF FISHERY SCI +2

A method for multiplying white-feathered broiler chickens using primordial germ cell stem cell lines

The present invention discloses a method for propagating white-feathered broiler chickens using primordial germ cell stem cell lines, in which the primordial germ cell stem cell lines of white-feathered broiler chickens cultured in a laboratory for a long time are injected into the embryos of laying hens, and white-feathered broiler chickens are obtained from the next generation of laying hens. Compared with the traditional method, the method for propagating white-feathered broiler chickens using primordial germ cell stem cell lines provided by the present invention provides a new breeding platform, and solves the problems of long time consumption, difficult management and animal welfare in the breeding process of white-feathered broiler chickens.
Owner:威奥福生物科技(宁波)有限公司

Construction method and application of a motor neuron MNX1 reporter gene cell line

The application discloses a kind of construction methods and applications of motor neuron MNX1 reporter cell lines, belong to gene editing and stem cell technical field.The application develops a kind of expression motor neuron MNX1 reporter gene vector system by screening high-activity sgRNA, and vector system includes the guide vector of single-stranded guide RNA targeted to the vicinity of the termination codon of human motor neuron MNX1 gene, and the donor vector carrying the homologous arm in the vicinity of the termination codon of human motor neuron MNX1 gene.The application also includes the construction method of MNX1 reporter gene human pluripotent stem cell line into the above-mentioned vector system, the application can be applied to identify stem cell differentiation source human motor neuron, and the morphology and function of motor neuron are researched under the condition of living cell, provide important platform for the pathogenesis research of muscle-related disease, treatment method evaluation and new treatment target exploration.
Owner:SHANGHAI YANGZHI REHABILITATION HOSPITAL

A stem cell line regulating porcine OCT4 gene expression and its construction method

PendingCN123108154ADomestic pigStem cell line
This invention provides a stem cell line for regulating porcine OCT4 gene expression and its construction method, belonging to the field of genetic engineering technology. This invention provides the application of the stem cell line regulating porcine OCT4 expression in the analysis of the regulatory mechanism of vertebral number variation in domestic pigs. Using 293T cells as the production host, overexpressing and knocking down lentiviral vectors were prepared, and then these vectors were used to obtain porcine OCT4-overexpressing and knockdown-expressing stem cell lines through infection. The OCT4-overexpressing and knockdown-expressing stem cell lines obtained by this invention can be used to study the regulatory mechanism of vertebral number variation in domestic pigs, providing important basic data for phenotypic research and genetic breeding of the quantitative trait of body segments in domestic pigs.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Construction method of human haploid blastocyst

The invention relates to a construction method of a human haploid blastoid, which comprises the following steps: firstly, sorting haploid cells, and placing the haploid cells in a human blastoid induction system to generate a human haploid blastoid-like structure with haploid attributes, namely the human haploid blastoid; the constructed human haploid blastoid has a structure and cell composition similar to those of a human blastocyst, and human embryonic stem cell lines, human trophoblast stem cell lines and human extraembryonic endoderm stem cell lines can also be established in different cell induction culture solutions. The human haploid blastoid has the structure and function similar to those of a human blastocyst, also has the advantages of haploid cells, and can be used for research on generation of human haploid embryo related cell lines, genetic screening of human early embryonic development and the like.
Owner:NANKAI UNIV

Real-time chemical screening method using liver organoids fluorescently labeled with cytochrome p450 1a1 enzyme

The present disclosure relates to a real-time chemical screening method using hepatic organoids fluorescently labeled with cytochrome P450 1A1 enzyme. The method for screening an AHR modulator or a hazardous chemical using CYP1A1 fluorescently labelled human pluripotent stem cell line-derived hepatic organoids according to the present disclosure enables the detection of substances that induce CYP1A1 regulation with higher sensitivity than when using the conventional human pluripotent stem cell line-derived hepatocytes by using hepatic organoids that can mimic the human body, and thus can be usefully utilized for early screening of new toxic or carcinogenic compounds while replacing animal testing.
Owner:KOREA RES INST OF CHEM TECH

Alzheimer's disease risk gene defect nerve cell as well as preparation method and application thereof

The invention discloses an Alzheimer's disease risk gene defect nerve cell as well as a preparation method and application thereof. The engineered induced pluripotent stem cell comprises an induced pluripotent stem cell which is deficient in ABCA7 gene and expresses a neural differentiation transcription factor in an inducible manner. According to the present invention, the Alzheimer's disease (AD) risk gene defect is introduced into the existing pluripotent stem cell line through the CRISPR and other gene editing means, and the inducible expression neural differentiation transcription factor is introduced through the lentiviral vector so as to establish the engineered AD risk gene defect pluripotent stem cell line, the engineered AD risky gene defect pluripotent stem cell line can be used for rapidly preparing nerve cells with Alzheimer's disease related A beta pathological phenotypes in a large scale by adding antibiotics for induced differentiation and screening culture, and is used for researching AD related pathogenesis and intervention means.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Skeletal and hematopoietic micro-environment

The present invention relates to a ground extracellular matrix (ECM) produced by a human stem cell line with chondrogenic activity, wherein the human stem cell line is genetically modified to overexpress Bone Morphogenetic Protein-2 (BMP-2). The invention further relates to a composition comprising said extracellular matrix, and a gel-like substrate or precursor thereof. The invention further relates to a kit comprising said composition. The invention further relates to a method of manufacturing said composition. The invention further relates to a method for bone and / or bone marrow formation in vivo. The invention further relates to a method for testing a candidate pharmaceutical product. The invention further relates to a method for identifying treatment responders. The invention further relates to said composition for use in medicine.
Owner:BOURGINE PAUL +1

Induced pluripotent stem cell capable of overcoming immunogenicity as well as establishment method and application thereof

The invention discloses an establishment method of induced pluripotent stem cells capable of overcoming immunogenicity and derived mesenchymal stem cells of the induced pluripotent stem cells, belongs to the technical field of biology, and solves the problems of limited passage times, large individual difference and immunological rejection of the mesenchymal stem cells in the prior art. The method comprises the following steps: reprogramming starting somatic cells to establish an induced pluripotent stem cell line, and continuously picking monoclonal passage to obtain a monoclonal induced pluripotent stem cell line; and performing beta2-microglobulin knockout on the monoclonal induced pluripotent stem cell strain to obtain beta2-microglobulin knockout induced pluripotent stem cell monoclone, namely the induced pluripotent stem cell capable of overcoming immunogenicity. The invention develops a method for inducing wild type and B2M knockout type hiPSC to differentiate into the iMSC by regulating an embryonic development signal channel to generate the iMSC, and the differentiated iMSC-WT and iMSC-KO are extremely similar to UCMSC in phenotype.
Owner:SHANGHAI TONGJIN STEM CELL TECHNOLOGY CO LTD

Serum-free culture method for converting hUC-MSCs into hiPSCs through small molecule compound induction

The invention provides a serum-free culture method for converting hUC-MSCs into hiPSCs through induction of a small molecule compound, can be used for preparing pluripotent stem cells, and belongs to the field of biomedicine. Comprising thymine analogs, cAMP activators, TGF-beta receptor inhibitors, bone morphogenetic proteins, RA receptor activators, GSK3 inhibitors and basic fibroblast growth factors, and the culture system does not contain serum. And 2, in the process of carrying out micromolecule compound reprogramming on the hUC-MSCs by utilizing the method provided by the invention, frequent digestion, inoculation and tray separation on the hUC-MSCs are not needed, so that compared with the existing culture method, the operation steps are simplified, the cell loss generated in the digestion, inoculation and tray separation process is reduced, and the cell quality is improved. According to the invention, the reprogramming efficiency of the small molecule compound on hUC-MSCs is obviously improved; and 3, by detecting the co-expression (such as OCT4, SOX2 and NANOG) of transcription factors in reprogrammed cells of a small molecule compound reprogrammed pluripotent stem cell line obtained by the technology, it is proved that the hiPSCs obtained by inducing the hUC-MSCs have stable pluripotency capable of continuous passage.
Owner:HUNAN HUIYISEN CELL GENETIC ENG CO LTD